352 related articles for article (PubMed ID: 18413693)
1. Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.
Clay PG; Voss LE; Williams C; Daume EC
Ann Pharmacother; 2008 May; 42(5):670-9. PubMed ID: 18413693
[TBL] [Abstract][Full Text] [Related]
2. Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.
Bryant ML; Worthington MA; Parsons K
Ann Pharmacother; 2009 Apr; 43(4):714-20. PubMed ID: 19336653
[TBL] [Abstract][Full Text] [Related]
3. Teriparatide for severe osteoporosis.
Cappuzzo KA; Delafuente JC
Ann Pharmacother; 2004 Feb; 38(2):294-302. PubMed ID: 14742769
[TBL] [Abstract][Full Text] [Related]
4. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
Inderjeeth CA; Foo AC; Lai MM; Glendenning P
Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
[TBL] [Abstract][Full Text] [Related]
6. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
Woodis CB
Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
[TBL] [Abstract][Full Text] [Related]
7. Emerging bone problems in patients infected with human immunodeficiency virus.
Mondy K; Tebas P
Clin Infect Dis; 2003 Apr; 36(Suppl 2):S101-5. PubMed ID: 12652379
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone (1-84) and treatment of osteoporosis.
Shrader SP; Ragucci KR
Ann Pharmacother; 2005 Sep; 39(9):1511-6. PubMed ID: 16076911
[TBL] [Abstract][Full Text] [Related]
9. [Musculoskeletal disorders in HIV-infected patients.National AIDS Plan (PNS) and the AIDS Study Group (GESIDA)].
Grupo de Expertos del Plan Nacional sobre el Sida y Grupo de Estudio de Sida
Enferm Infecc Microbiol Clin; 2011; 29(7):515-23. PubMed ID: 21474209
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
[TBL] [Abstract][Full Text] [Related]
11. Bone disorders in human immunodeficiency virus infection.
Glesby MJ
Clin Infect Dis; 2003; 37 Suppl 2():S91-5. PubMed ID: 12942380
[TBL] [Abstract][Full Text] [Related]
12. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral abnormalities in persons with HIV infection: signal or noise?
Singh K; Moyle GJ
AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
[TBL] [Abstract][Full Text] [Related]
14. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
Amin S; LaValley MP; Simms RW; Felson DT
Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of osteoporosis and osteopenia in children--own experience].
Chlebna-Sokół D; Błaszczyk A; Rusińska A; Loba-Jakubowska E
Przegl Lek; 2003; 60(1):5-11. PubMed ID: 12884638
[TBL] [Abstract][Full Text] [Related]
16. Bone disease and HIV infection.
Amorosa V; Tebas P
Clin Infect Dis; 2006 Jan; 42(1):108-14. PubMed ID: 16323100
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic management of osteoprosis and osteopenia.
Alexander IM
Nurse Pract; 2009 Jun; 34(6):30-40; quiz 41. PubMed ID: 19474629
[No Abstract] [Full Text] [Related]
18. Apricitabine: a nucleoside reverse transcriptase inhibitor for HIV infection.
Gaffney MM; Belliveau PP; Spooner LM
Ann Pharmacother; 2009 Oct; 43(10):1676-83. PubMed ID: 19737995
[TBL] [Abstract][Full Text] [Related]
19. Bazedoxifene: a third-generation selective estrogen receptor modulator for treatment of postmenopausal osteoporosis.
Stump AL; Kelley KW; Wensel TM
Ann Pharmacother; 2007 May; 41(5):833-9. PubMed ID: 17426077
[TBL] [Abstract][Full Text] [Related]
20. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis.
Seminari E; De Silvestri A; Boschi A; Tinelli C
AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
